{"id":20493,"date":"2024-06-04T07:22:28","date_gmt":"2024-06-04T11:22:28","guid":{"rendered":"https:\/\/massivebio.com\/?p=20493"},"modified":"2025-09-24T10:38:30","modified_gmt":"2025-09-24T07:38:30","slug":"massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care","status":"publish","type":"post","link":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/","title":{"rendered":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching"},"content":{"rendered":"\r\n<p><style>\r\n@media only screen and (max-width: 768px) {\r\n.blog-hero .info-area .name {\r\n    margin: 15px 0 20px;\r\n    font-size: 32px;\r\n    font-weight: 500;\r\n    line-height: 45px;\r\n}    \r\n}\r\n<\/style><\/p>\r\n\r\n\r\n\r\n<h2 style=\"font-size: 18px; line-height: 28px;\"><strong>Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching<\/strong><\/h2>\r\n\r\n\r\n\r\n<p><strong>June 4<sup>th<\/sup> 2024, ASCO Annual Meeting, Chicago \u2013<\/strong> Inocras, a leading AI-driven whole genome testing company, and Massive Bio, an cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer patient care. This strategic collaboration leverages Inocras&#8217;s expertise in whole genome sequencing (WGS) and bioinformatics alongside Massive Bio&#8217;s advanced AI technology for clinical trial matching, with the shared mission of enhancing personalized care for cancer patients.<\/p>\r\n\r\n\r\n\r\n<p>The cornerstone of this partnership lies in delivering the most comprehensive genetic testing using whole genome sequencing while simultaneously offering robust support for clinical trial matching to patients and healthcare providers alike. In addition, patients can get informed of future clinical trials without the need for additional genetic tests, courtesy of the expansive nature of the whole genome data.\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n<p>Inocras stands at the forefront of advanced whole genome testing, a groundbreaking technology capable of identifying rare and complex mutations often overlooked by conventional genetic tests like standard panel sequencing or whole exome sequencing tests. In an effort to streamline the access to whole genome testing for cancer patients and their providers, the company recently unveiled an user-friendly <a href=\"http:\/\/inocras.com\" target=\"_blank\" rel=\"noreferrer noopener\">digital platform<\/a>.\u00a0<\/p>\r\n\r\n\r\n\r\n<p>Rebecca Jang, Chief of Strategy Officer of Inocras, emphasizes the significance of the strategic alliance. &#8220;While we excel in WGS testing, which captures more and deeper insights on patients\u2019 cancer, not all patients have available treatment options matched with their biomarkers. For them, clinical trials are their next hope. Given the historically burdensome task of finding suitable clinical trials for cancer patients, partnering with Massive Bio is paramount. Our robust biomarker data will be further enriched by Massive Bio&#8217;s capabilities, facilitating more precise patient matching with effective clinical trials. All of these will be on a single digital platform.&#8221;<\/p>\r\n\r\n\r\n\r\n<p>Massive Bio is building the largest global oncology\/hematology network to transform patient recruitment at scale with more than 120,000 patients, 5,000 physicians, 40 Pharma and CRO Customers, and 50 Partners. Massive Bio\u2019s real-time, AI-driven platform, Synergy-AI, can analyze and summarize extensive medical records, including biomarker data from multiple sources, to match patients with over 14,000 clinical trials instantly. Massive Bio\u2019s predictive analytics maximizes trial enrollment potential and significantly reduces screen failures.<\/p>\r\n\r\n\r\n\r\n<p>Toygun Onaran, Chief Financial Officer of Massive Bio, notes the significance of the partnership: &#8221; We are setting a new standard in cancer care, emphasizing a data-driven and patient-centric approach by harnessing the power of AI and cutting-edge genomic testing to increase access for cancer patients benefiting from precision medicine. This collaboration is a testament to our commitment to offering cancer patients the best care possible, tailored to their unique genetic profiles.&#8221;<\/p>\r\n\r\n\r\n\r\n<p>The combined expertise and innovative solutions of both companies promise to usher a new era in personalized cancer care. Both parties highlighted, \u201cTogether, we are charting a transformative path for cancer patients.\u201d<\/p>\r\n\r\n\r\n\r\n<p><strong>For more details on this transformative initiative, visit<\/strong> <a href=\"http:\/\/www.inocras.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Inocras<\/strong><\/a><strong> and <\/strong><a href=\"https:\/\/massivebio.com\/\" target=\"_blank\" rel=\"noreferrer noopener\"><strong>Massive Bio<\/strong><\/a><strong>.<\/strong><\/p>\r\n\r\n\r\n\r\n<p><strong>About Inocras Inc:<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Inocras Inc. (formerly Genome Insight, Inc) is a pioneering provider of whole genome sequencing and analytics services for cancer and rare diseases. The company is dedicated to unlocking the potential of whole genomic data to enable precision health for everyone.<\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching June 4th 2024, ASCO Annual Meeting, Chicago \u2013 Inocras, a leading AI-driven whole genome testing company, and Massive Bio, an cutting-edge AI-driven clinical trial matching platform provider, have joined forces to set a new standard for cancer&#8230;<\/p>\n","protected":false},"author":11,"featured_media":23960,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[55],"tags":[],"class_list":["post-20493","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching<\/title>\n<meta name=\"description\" content=\"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching %\" \/>\n<meta property=\"og:description\" content=\"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching\" \/>\n<meta property=\"og:url\" content=\"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/\" \/>\n<meta property=\"og:site_name\" content=\"Massive Bio\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-04T11:22:28+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-24T07:38:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"576\" \/>\n\t<meta property=\"og:image:height\" content=\"432\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sinan Gul\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:site\" content=\"@MassiveBio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sinan Gul\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","description":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/","og_locale":"en_US","og_type":"article","og_title":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching %","og_description":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","og_url":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/","og_site_name":"Massive Bio","article_publisher":"https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","article_published_time":"2024-06-04T11:22:28+00:00","article_modified_time":"2025-09-24T07:38:30+00:00","og_image":[{"width":576,"height":432,"url":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg","type":"image\/jpeg"}],"author":"Sinan Gul","twitter_card":"summary_large_image","twitter_creator":"@MassiveBio","twitter_site":"@MassiveBio","twitter_misc":{"Written by":"Sinan Gul","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#article","isPartOf":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/"},"author":{"name":"Sinan Gul","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6"},"headline":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","datePublished":"2024-06-04T11:22:28+00:00","dateModified":"2025-09-24T07:38:30+00:00","mainEntityOfPage":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/"},"wordCount":555,"publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"image":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/","url":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/","name":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","isPartOf":{"@id":"https:\/\/massivebio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#primaryimage"},"image":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#primaryimage"},"thumbnailUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg","datePublished":"2024-06-04T11:22:28+00:00","dateModified":"2025-09-24T07:38:30+00:00","description":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching","breadcrumb":{"@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#primaryimage","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2024\/06\/INOCRAS_576-432-min.jpg","width":576,"height":432,"caption":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching"},{"@type":"BreadcrumbList","@id":"https:\/\/massivebio.com\/massivebio-and-inocras-forge-groundbreaking-alliance-to-revolutionize-cancer-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Homepage","item":"https:\/\/massivebio.com\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/massivebio.com\/resources\/news-en\/"},{"@type":"ListItem","position":3,"name":"Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching"}]},{"@type":"WebSite","@id":"https:\/\/massivebio.com\/#website","url":"https:\/\/massivebio.com\/","name":"Cancer Analysis and Clinical Trial Matching","description":"Best Oncology Advisory Services By Cancer Treatment Care Specialists &amp; Tumor Board Experts in America","publisher":{"@id":"https:\/\/massivebio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/massivebio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/massivebio.com\/#organization","name":"Massive Bio","url":"https:\/\/massivebio.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/","url":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","contentUrl":"https:\/\/massivebio.com\/wp-content\/uploads\/2025\/01\/Massive-Bio-Logo-Circle.svg","width":"1024","height":"1024","caption":"Massive Bio"},"image":{"@id":"https:\/\/massivebio.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/facebook.com\/people\/Massive-Bio-As\/100094663612187\/","https:\/\/x.com\/MassiveBio","https:\/\/instagram.com\/massive_bio\/","https:\/\/tiktok.com\/@massivebio","https:\/\/youtube.com\/massivebio"],"email":"support@massivebio.com","legalName":"Massive Bio"},{"@type":"Person","@id":"https:\/\/massivebio.com\/#\/schema\/person\/961d749445523a588f7ffb7086d037c6","name":"Sinan Gul"}]}},"_links":{"self":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/20493","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/comments?post=20493"}],"version-history":[{"count":3,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/20493\/revisions"}],"predecessor-version":[{"id":37769,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/posts\/20493\/revisions\/37769"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media\/23960"}],"wp:attachment":[{"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/media?parent=20493"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/categories?post=20493"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/massivebio.com\/wp-json\/wp\/v2\/tags?post=20493"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}